Amylin sold 4M shares of newly issued stock at $3.25 each to 2 new institutional investors and to company insiders, including Joseph Cook Jr., chairman and CEO, and Howard (Ted) Greene, cofounder and director; also investing were the State of Wisconsin Investment Board, a current institutional investor and certain other individual investors; Hambrecht & Quist LLC acted as advisor (7/98)
Ariad Pharmaceuticals Inc.
2.54
10.2
Ariad sold 2.54M newly registered shares of common stock at $4/share to new institutional investors; BancAmerica Robertson Stephens acted as the placement agent (5/98)
See subscription options